104540 — CORENTEC CO Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Annual income statement for CORENTEC CO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	44,630	63,909	92,046	85,594	100,429
Cost of Revenue
Gross Profit	27,179	39,951	51,698	44,284	52,094
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	41,840	56,411	85,699	83,338	95,181
Operating Profit	2,790	7,498	6,347	2,256	5,247
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,056	2,465	6,787	-384	5,222
Provision for Income Taxes
Net Income After Taxes	764	2,651	5,135	-1,860	5,065
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	764	1,781	4,055	-2,585	6,259
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	764	1,781	4,055	-2,585	6,535
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	118	57.7	280	-196	581
Dividends per Share